Literature DB >> 3929319

Repeated treatment with imipramine potentiates the locomotor effect of apomorphine administered into the hippocampus in rats.

A Smiałowski, J Maj.   

Abstract

The effect of apomorphine, injected into the dorsal hippocampus, on the locomotor activity of imipramine-treated rats was studied. The rats were chronically implanted with cannulae 1 week before imipramine treatment. Imipramine was given in a dose of 10 mg/kg per os, acutely, or twice a day for 14 days. Intrahippocampal injection of apomorphine induced a dose-dependent increase in locomotor activity. This effect was antagonized by pretreatment with pimozide (2 mg/kg). Repeated, but not single, administrations of imipramine significantly enhanced the apomorphine-induced locomotor hyperactivity in rats. This effect was observed at 2, 48 and 96 h after the last dose of imipramine. The results obtained indicate that repeated administration of imipramine increases the responsiveness of the hippocampal dopaminergic system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3929319     DOI: 10.1007/bf00427910

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  The effect of intrahippocampal administration of dopamine or apomorphine on EEG of limbic structures in the rabbit brain.

Authors:  A Smialowski
Journal:  Pol J Pharmacol Pharm       Date:  1976 Nov-Dec

2.  Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H]leucine and horseradish peroxidase.

Authors:  H Simon; M Le Moal; A Calas
Journal:  Brain Res       Date:  1979-12-07       Impact factor: 3.252

3.  Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine.

Authors:  J Maj; Z Rogóz; G Skuza; H Sowińska
Journal:  J Pharm Pharmacol       Date:  1984-02       Impact factor: 3.765

4.  The route of administration of imipramine as a factor affecting formation of its metabolite desipramine.

Authors:  W Daniel; A Adamus; M Melzacka; J Szymura
Journal:  J Pharm Pharmacol       Date:  1982-10       Impact factor: 3.765

5.  Chronic treatment with antidepressant drugs: potentiation of apomorphine-induced aggressive behaviour in rats.

Authors:  J Maj; E Mogilnicka; A Kordecka
Journal:  Neurosci Lett       Date:  1979-08       Impact factor: 3.046

6.  The distribution of apomorphine in rat brain: possible behavioral correlates.

Authors:  M Melzacka; G Wiszniowska; J Vetulani
Journal:  Pol J Pharmacol Pharm       Date:  1978 Mar-Jun

7.  Modulation of dopamine-mediated behavioural responses by antidepressants: effects of single and repeated treatment.

Authors:  A Delini-Stula; A Vassout
Journal:  Eur J Pharmacol       Date:  1979-10-15       Impact factor: 4.432

8.  Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants.

Authors:  M T Martin-Iverson; J F Leclere; H C Fibiger
Journal:  Eur J Pharmacol       Date:  1983-10-28       Impact factor: 4.432

9.  Chronic treatment with imipramine: further functional evidence for the enhanced noradrenergic transmission in flexor reflex activity.

Authors:  J Maj; Z Górka; M Melzacka; A Rawłów; A Pilc
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-05       Impact factor: 3.000

10.  Chronic treatment with antidepressants: protentiation of clonidine-induced aggression in mice via noradrenergic mechanism.

Authors:  J Maj; E Mogilnicka; V Klimek; A Kordecka-Magiera
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

View more
  7 in total

1.  The role of the direct perforant path input to the CA1 subregion of the dorsal hippocampus in memory retention and retrieval.

Authors:  David R Vago; Adam Bevan; Raymond P Kesner
Journal:  Hippocampus       Date:  2007       Impact factor: 3.899

2.  Disruption of the direct perforant path input to the CA1 subregion of the dorsal hippocampus interferes with spatial working memory and novelty detection.

Authors:  David R Vago; Raymond P Kesner
Journal:  Behav Brain Res       Date:  2008-01-15       Impact factor: 3.332

3.  Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonist.

Authors:  J Maj; Z Rogóz; G Skuza; H Sowińska
Journal:  J Neural Transm Gen Sect       Date:  1989

4.  Behavioral changes and dopaminergic dysregulation in mice lacking the nuclear receptor Rev-erbα.

Authors:  Jennifer Jager; W Timothy O'Brien; Jessica Manlove; Elizabeth N Krizman; Bin Fang; Zachary Gerhart-Hines; Michael B Robinson; Peter S Klein; Mitchell A Lazar
Journal:  Mol Endocrinol       Date:  2014-02-19

5.  Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens.

Authors:  J C Barnes; B Costall; A M Domeney; R J Naylor
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  The influence of repeated treatment with imipramine, (+)- and (-)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists.

Authors:  J Maj; M Papp; G Skuza; K Bigajska; M Zazula
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

7.  Repeated imipramine enhances sensitivity of the brain dopaminergic system related to exploratory behavior.

Authors:  A Smiałowski
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.